EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analytical Performance and Potential Clinical Utility of EUCAST Rapid Antimicrobial Susceptibility Testing in Blood Cultures after Four Hours of Incubation

Anna Ekwall-Larson, Inga Fröding, Berivan Mert, Anna Åkerlund, Volkan Özenci iD

Microbiology Spectrum · 13.04.2023 · 11 (2)

DOI: 10.1128/spectrum.05001-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 13.04.2023. Verfasst von Anna Ekwall-Larson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Karolinska University Hospital, Huddinge, Stockholm, Sweden. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet (KI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early effective antimicrobial treatment has been shown to be crucial for improving the outcome of bloodstream infections (BSI) and sepsis. In combination with the rise of antibiotic resistance, this calls for accelerated methods for antibiotic susceptibility testing (AST) for effective treatment of BSI.

Schlagwörter

Stichwörter der Autor:innen

ESBLantibiotic resistanceblood culturebloodstream infectionrapid testssusceptibility testing

Autor:innen und Institutionen

  • Department of Clinical Microbiology, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
  • Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.
  • Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
  • Division of Clinical Microbiology, Department of Clinical and Experimental Medicine, Linköping University Hospital, Linköping, Sweden.
  • Division of Clinical Microbiology, Linköping University Hospital, Linköping, Sweden.

ORCID-Profile: Volkan Özenci

Förderung

  • Karolinska Institutet (KI)

Zitieren

APA

Ekwall-Larson, A., Fröding, I., Mert, B., Åkerlund, A., & Özenci, V. (2023). Analytical Performance and Potential Clinical Utility of EUCAST Rapid Antimicrobial Susceptibility Testing in Blood Cultures after Four Hours of Incubation. Microbiology Spectrum, 11(2). https://doi.org/10.1128/spectrum.05001-22

Vancouver

Ekwall-Larson A, Fröding I, Mert B, Åkerlund A, Özenci V. Analytical Performance and Potential Clinical Utility of EUCAST Rapid Antimicrobial Susceptibility Testing in Blood Cultures after Four Hours of Incubation. Microbiology Spectrum. 2023;11(2). doi:10.1128/spectrum.05001-22

BibTeX
@article{EkwallLarson2023,
  author = {Ekwall-Larson, Anna and Fröding, Inga and Mert, Berivan and Åkerlund, Anna and Özenci, Volkan},
  title = {Analytical Performance and Potential Clinical Utility of EUCAST Rapid Antimicrobial Susceptibility Testing in Blood Cultures after Four Hours of Incubation},
  journal = {Microbiology Spectrum},
  year = {2023},
  volume = {11},
  number = {2},
  doi = {10.1128/spectrum.05001-22}
}
Kostenlos starten →